Remedy Plan Therapeutics: Funding, Investors & Team (Oct 2026)
Remedy Plan Therapeutics is a pre-clinical-stage company developing small molecule therapeutics to halt tumor growth and disrupt the cancer stem cells that cause metastasis. Our approach is to develop effective, non-toxic treatments that target the dangerous embryonic properties of cancer stem cells, which form the basis for cancer growth, spread, and resistance to chemotherapy. Remedy Plan is positioned to deliver one first-in-class drug candidate for Phase I clinical development approximately 15 months after Series A funding Remedy Plan's proprietary drug screening platform identifies drug candidates that differentiate cancer stem cells, disrupt proliferation, and inhibit formation of new tumors. From the initial screen of 40,000 drug components, a lead candidate is currently undergoing optimization and mechanism of action studies in preparation for Phase I clinical trials. With the second screen of over 100,000 drug components completed, Remedy Plan aims to have at least two drugs in clinical development by 2020.
Remedy Plan Therapeutics has raised $37.1M across 2 funding rounds on record, the most recent an undisclosed round of $18.0M announced in May 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Remedy Plan Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2025.
Remedy Plan Therapeutics Funding Rounds
Remedy Plan Therapeutics raised $19.1M in an undisclosed round announced in Aug 2023.
1.8 years later, an undisclosed round of $18.0M was announced in May 2025.
Remedy Plan Therapeutics Founders and Leadership Team
Contact details for the Remedy Plan Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Remedy Plan Therapeutics Funding Compared to Other Biotechnology Startups
Remedy Plan Therapeutics' latest round of $18.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Remedy Plan Therapeutics in Biotechnology and Gaithersburg
Companies Similar to Remedy Plan Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Remedy Plan Therapeutics Funding FAQs
What does Remedy Plan Therapeutics do?
Remedy Plan Therapeutics is a pre-clinical-stage company developing small molecule therapeutics to halt tumor growth and disrupt the cancer stem cells that cause metastasis. Our approach is to develop effective, non-toxic treatments that target the dangerous embryonic properties of cancer stem cells, which form the basis for cancer growth, spread, and resistance to chemotherapy. Remedy Plan is positioned to deliver one first-in-class drug candidate for Phase I clinical development approximately 15 months after Series A funding Remedy Plan's proprietary drug screening platform identifies drug candidates that differentiate cancer stem cells, disrupt proliferation, and inhibit formation of new tumors. From the initial screen of 40,000 drug components, a lead candidate is currently undergoing optimization and mechanism of action studies in preparation for Phase I clinical trials. With the second screen of over 100,000 drug components completed, Remedy Plan aims to have at least two drugs in clinical development by 2020.
How much funding has Remedy Plan Therapeutics raised?
Remedy Plan Therapeutics has raised $37.1M across 2 rounds on record. The most recent is an undisclosed round of $18.0M announced in May 2025.
When did Remedy Plan Therapeutics last raise funding?
Remedy Plan Therapeutics' most recent funding round on record is an undisclosed round of $18.0M, announced in May 2025.
Who founded Remedy Plan Therapeutics?
FundedIQ lists Gregory Crimmins (Founder) at Remedy Plan Therapeutics.
Where is Remedy Plan Therapeutics headquartered?
Remedy Plan Therapeutics is based in Gaithersburg, Maryland, United States.
How many employees does Remedy Plan Therapeutics have?
Remedy Plan Therapeutics is in the 11-50 employee band.
How does Remedy Plan Therapeutics' funding compare to other Biotechnology startups?
Remedy Plan Therapeutics' latest round of $18.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Remedy Plan Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Remedy Plan Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.